Shoulder Innovations CEO exercises 89K options
SHOULDER INNOVATIONS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
SHOULDER INNOVATIONS, INC. (SI) reports that CEO & Executive Chairman Robert Joseph Ball exercised stock options to acquire 89,233 shares of Common Stock on September 14, 2026 at an exercise price of $2.0988 per share, from a fully vested, currently exercisable option expiring December 16, 2030. On the same date, he sold 10,175 shares of Common Stock at a weighted average price of $18.4478 per share, with sale prices ranging from $18.22 to $18.63; the disclosure states these shares were sold solely to cover the exercise price. The filing notes that his Common Stock holdings include 1,748 shares acquired on June 30, 2026 under the 2025 Employee Stock Purchase Plan, and no Rule 10b5-1 trading plan is reported.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Ball Robert Joseph
Role
CEO & Executive Chairman
Sold
10,175 shs ($188K)
Approx. gross sale proceeds
$188K
Approx. exercise cost
$187K
Share of Position Sold
2.6%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F3 | 89,233 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 89,233 | $2.0988 | $187K |
| Sale | Common Stock F2 | 10,175 | $18.4478 | $188K |
Holdings After Transaction:
Stock Option — 92,143 contracts (Direct);
Common Stock — 380,824 shares (Direct)
Holdings Before and After:
Stock Option, 181,376 to 92,143 contracts (Direct);
Common Stock, 301,766 to 380,824 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
- F1. Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan.
- F2. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.22 to $18.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The shares of Common Stock were sold solely to cover the exercise price in connection with the exercise of the stock option.
- F3. The stock option is fully vested and currently exercisable.
Key Figures
Shares acquired via option exercise: 89,233 shares
Option exercise price: $2.0988 per share
Shares sold: 10,175 shares
+4 more
7 metrics
Shares acquired via option exercise
89,233 shares
Common Stock acquired by option exercise on September 14, 2026
Option exercise price
$2.0988 per share
Exercise price for 89,233-share stock option
Shares sold
10,175 shares
Common Stock sold on September 14, 2026
Weighted average sale price
$18.4478 per share
Sale prices ranged from $18.22 to $18.63 per share
Stock option expiration
December 16, 2030
Expiration date of the exercised stock option
Shares from Employee Stock Purchase Plan
1,748 shares
Common Stock acquired June 30, 2026 under 2025 Employee Stock Purchase Plan
Remaining stock options reported
92,143 options
Stock options held directly following the reported exercise
Key Terms
stock option, weighted average sale price, Employee Stock Purchase Plan, Common Stock
4 terms
stock option financial
"The stock option is fully vested and currently exercisable."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
Employee Stock Purchase Plan financial
"shares of Common Stock acquired ... pursuant to the Issuer's 2025 Employee Stock Purchase Plan."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Common Stock financial
"The shares of Common Stock were sold in multiple transactions"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SI’s CEO Robert Joseph Ball report in this Form 4 for SHOULDER INNOVATIONS, INC. (SI)?
He reported exercising stock options to acquire 89,233 shares of Common Stock at $2.0988 per share on September 14, 2026, and selling 10,175 shares at a weighted average price of $18.4478 per share on the same date.
What prices were involved in the SI stock transactions reported by the CEO?
The options were exercised at an exercise price of $2.0988 per share. The 10,175 shares of Common Stock sold were transacted at a weighted average price of $18.4478 per share, with individual sale prices ranging from $18.22 to $18.63.
What are the key terms of the stock option exercised by the SI CEO?
The reported stock option covered 89,233 underlying shares of Common Stock, had an exercise price of $2.0988 per share, is described as fully vested and currently exercisable, and carries an expiration date of December 16, 2030.
Does the SI Form 4 indicate trades under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no statement in the footnotes indicating that the reported transactions were made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
